p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo

Molecular and Cellular Biology

Volumn 26, Issue 16, 2006, Pages 6170-6184

  Soeiro, Inês ^a   Mohamedali, Azim ^b   Romanska, Hanna M ^a,c   Lea, Nicholas C ^b   Child, Emma S ^d   Glassford, Janet ^a   Orr, Stephen J ^b   Roberts, Claudia ^c   Naresh, Kikkeri N ^a   Lalani, El Nasir ^a,c   Mann, David J ^d   Watson, Roger J ^d   Thomas, N Shaun B ^b   Lam, Eric W F ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P130; BLOOD GROUP ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; RBL2 PROTEIN, MOUSE; TER 119 ANTIGEN, MOUSE; TER-119 ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL COUNT; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME REPRESSION; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC CELL; HYPERSENSITIVITY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHOID CELL; MACROPHAGE; MICROENVIRONMENT; MITOGENESIS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; CELL CULTURE; CELL CYCLE; CYTOLOGY; GENETICS; HEMATOPOIETIC SYSTEM; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; SPLEEN; THYMUS; UPREGULATION;

ANIMALIA;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD45; B-LYMPHOCYTES; BLOOD GROUP ANTIGENS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HEMATOPOIETIC SYSTEM; MICE; MICE, KNOCKOUT; PROTEIN BINDING; RETINOBLASTOMA-LIKE PROTEIN P130; SPLEEN; THYMUS GLAND; UP-REGULATION;

EID: 33746938836     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02182-05     Document Type: Article

References (47)

1. Bankfalvi, A., H. Navabi, B. Bier, W. Bocker, B. Jasani, and K. W. Schmid. 1994. Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J. Pathol. 174:223-228.
2. Castano, E., Y. Kleyner, and B. D. Dynlacht. 1998. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol. Cell. Biol. 18:5380-5391.
3. Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571-1583.
4. Cheng, T., N. Rodrigues, D. Dombkowski, S. Stier, and D. T. Scadden. 2000. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat. Med. 6:1235-1240.
5. Cheng, T., N. Rodrigues, H. Shen, Y. Yang, D. Dombkowski, M. Sykes, and D. T. Scadden. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804-1808.
6. Classon, M., B. K. Kennedy, R. Mulloy, and E. Harlow. 2000. Opposing roles of pRB and p107 in adipocyte differentiation. Proc. Natl. Acad. Sci. USA 97:10826-10831.
7. Classon, M., S. Salama, C. Gorka, R. Mulloy, P. Braun, and E. Harlow. 2000. Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc. Natl. Acad. Sci. USA 97:10820-10825.
8. Coats, S., P. Whyte, M. L. Fero, S. Lacy, G. Chung, E. Randel, E. Firpo, and J. M. Roberts. 1999. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Curr. Biol. 9:163-173.
9. Cobrinik, D., M. H. Lee, G. Hannon, G. Mulligan, R. T. Bronson, N. Dyson, E. Harlow, D. Beach, R. A. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10:1633-1644.
10. Collado, M., R. H. Medema, I. Garcia-Cao, M. L. Dubuisson, M. Barradas, J. Glassford, C. Rivas, B. M. Burgering, M. Serrano, and E. W.-F. Lam. 2000. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J. Biol. Chem. 275:21960-21968.
11. Dannenberg, J. H., L. Sthuijff, M. Dekker, M. van der Valk, and H. te Riele. 2004. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev. 18:2952-2962.
12. De Luca, A., T. K. MacLachlan, L. Bagella, C. Dean, C. M. Howard, P. P. Claudio, A. Baldi, K. Khalili, and A. Giordano. 1997. A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. J. Biol. Chem. 272: 20971-20974.
13. KIP1. Mol. Cell. Biol. 20:9138-9148.
14. Ezoe, S., I. Matsumura, Y. Satoh, H. Tanaka, and Y. Kanakura. 2004. Cell cycle regulation in hematopoietic stem/progenitor cells. Cell Cycle 3:314-318.
15. Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744.
16. Furukawa, Y. 2002. Cell cycle control genes and hematopoietic cell differentiation. Leuk. Lymphoma 43:225-231.
17. Glassford, J., M. Holman, L. Banerji, E. Clayton, G. G. Klaus, M. Turner, and E. W.-F. Lam. 2001. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen receptor. J. Biol. Chem. 276:41040-41048.
18. Hsieh, F. F., L. A. Barnett, W. F. Green, K. Freedman, I. Matushansky, A. I. Skoultchi, and L. L. Kelley. 2000. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Blood 96:2746-2754.
19. Hsu, S. M., L. Raine, and H. Fanger. 1981. Use of avidin-biotin- peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580.
20. Huleatt, J. W., J. Cresswell, K. Bottomly, and I. N. Crispe. 2003. P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawal. Immunology 108:493-501.
21. 1 arrest. Mol. Cell. Biol. 26:2430-2440.
22. Johnson-Leger, C., J. R. Christenson, M. Holman, and G. G. Klaus. 1998. Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. J. Immunol. 161:4618-4626.
23. Kiyokawa, H., R. D. Kineman, K. O. Manova-Todorova, V. C. Soares, E. S. Hoffman, M. Ono, D. Khanam, A. C. Hayday, L. A. Frohman, and A. Koff. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732.
24. Kops, G. J., R. H. Medema, J. Glassford, M. A. Essers, P. F. Dijkers, P. J. Coffer, E. W.-F. Lam, and B. M. Burgering. 2002. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell. Biol. 22:2025-2036.
25. Lam, E. W.-F., J. Glassford, L. Banerji, N. S. Thomas, P. Sicinski, and G. G. Klaus. 2000. Cyclin D3 compensates for loss of cyclin D2 in mouse B lymphocytes activated via the antigen receptor and CD40. J. Biol. Chem. 275:3479-3484.
26. Lam, E. W.-F., and N. B. La Thangue. 1994. DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 6:859-866.
27. 1 that controls entry into the cell cycle. Mol. Cell. Biol. 23:2351-2361.
28. LeCouter, J. E., B. Kablar, P. F. Whyte, C. Ying, and M. A. Rudnicki. 1998. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125:4669-4679.
29. Matsuoka, S., M. C. Edwards, C. Bai, S. Parker, P. Zhang, A. Baldini, J. W. Harper, and S. J. Elledge. 1995. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
30. Mohapatra, S., D. Agrawal, and W. J. Pledger. 2001. p27Kip1 regulates T cell proliferation. J. Biol. Chem. 276:21976-21983.
31. Morel, F., S. Salimi, J. Markovits, T. W. Austin, and I. Plavec. 1999. Hematologic recovery in mice transplanted with bone marrow stem cells expressing anti-human immunodeficiency virus genes. Hum. Gene Ther. 10: 2779-2787.
32. Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, and D. Y. Loh. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
33. Okada, S., H. Nakauchi, K. Nagayoshi, S. Nishikawa, S. Nishikawa, Y. Miura, and T. Suda. 1991. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706-1712.
34. 1 events and regulation of cell proliferation. Science 246:603-608.
35. Rane, S. G., and E. P. Reddy. 2002. JAKs, STATs and Src kinases in hematopoiesis. Oncogene 21:3334-3358.
36. Ruiz, S., M. Santos, C. Segrelles, H. Leis, J. L. Jorcano, A. Berns, J. M. Paramio, and M. Vooijs. 2004. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 131:2737-2748.
37. 1-phase progression. Genes Dev. 13:1501-1512.
38. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
39. Steinman, R. A. 2002. Cell cycle regulators and hematopoiesis. Oncogene 21:3403-3413.
40. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. el-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396.
41. Taniguchi, T., H. Endo, N. Chikatsu, K. Uchimaru, S. Asano, T. Fujita, T. Nakahata, and T. Motokura. 1999. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 93:4167-4178.
42. Vidal, A., S. Zacharoulis, W. Guo, D. Shaffer, F. Giancotti, A. H. Bramley, C. de la Hoz, K. K. Jensen, D. Kato, D. D. MacDonald, J. Knowles, N. Yeh, L. A. Frohman, S. Rafii, D. Lyden, and A. Koff. 2005. p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow. Proc. Natl. Acad. Sci. USA 102:6890-6895.
43. Williams, C. D, D. C. Linch, M. J. Watts, and N. S. Thomas. 1997. Characterization of cell cycle status and E2F complexes in mobilized CD34 + cells before and after cytokine stimulation. Blood 90:194-203.
44. Woo, M. S., I. Sanchez, and B. D. Dynlacht. 1997. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol. Cell. Biol. 17:3566-3579.
45. 1/S cyclin-dependent kinases. J. Biol. Chem. 272:12738-12746.
46. Zhan, Y., S. Basu, G. J. Lieschke, D. Grail, A. R. Dunn, and C. Cheers. 1999. Functional deficiencies of peritoneal cells from gene-targeted mice lacking G-CSF or GM-CSF. J. Leukoc. Biol. 65:256-264.
47. Zhu, L., E. Harlow, and B. D. Dynlacht. 1995. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1740-1752.